- Home
- TRSG vs ESLA Comparison
TRSG vs ESLA Comparison
Compare TRSG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- ESLA
- Stock Information
- Founded
- TRSG 1996
- ESLA 2021
- Country
- TRSG Singapore
- ESLA United States
- Employees
- TRSG N/A
- ESLA N/A
- Industry
- TRSG
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRSG
- ESLA Health Care
- Exchange
- TRSG NYSE
- ESLA Nasdaq
- Market Cap
- TRSG 35.2M
- ESLA 41.6M
- IPO Year
- TRSG 2024
- ESLA N/A
- Fundamental
- Price
- TRSG $2.16
- ESLA $0.89
- Analyst Decision
- TRSG
- ESLA
- Analyst Count
- TRSG 0
- ESLA 0
- Target Price
- TRSG N/A
- ESLA N/A
- AVG Volume (30 Days)
- TRSG 15.8K
- ESLA 15.5K
- Earning Date
- TRSG 11-29-2024
- ESLA 11-14-2024
- Dividend Yield
- TRSG N/A
- ESLA N/A
- EPS Growth
- TRSG N/A
- ESLA N/A
- EPS
- TRSG 0.06
- ESLA N/A
- Revenue
- TRSG $14,362,502.00
- ESLA N/A
- Revenue This Year
- TRSG N/A
- ESLA N/A
- Revenue Next Year
- TRSG N/A
- ESLA N/A
- P/E Ratio
- TRSG $37.85
- ESLA N/A
- Revenue Growth
- TRSG N/A
- ESLA N/A
- 52 Week Low
- TRSG $2.06
- ESLA $0.63
- 52 Week High
- TRSG $11.78
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- ESLA 52.17
- Support Level
- TRSG N/A
- ESLA $0.74
- Resistance Level
- TRSG N/A
- ESLA $0.99
- Average True Range (ATR)
- TRSG 0.00
- ESLA 0.10
- MACD
- TRSG 0.00
- ESLA 0.02
- Stochastic Oscillator
- TRSG 0.00
- ESLA 66.10
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.